Abstract
We made a prospective study using vaginal suppository of Géméprost (analogue of PGE1) and intravenous infusion of Sulprostone (analogue of PGE2) in thirty second- and third-trimesters pregnancy terminations. The efficacy was excellent for both procedures: only one failure, mean duration of abortion of 15 h 15 with Sulprostone, interval of 17 hours with Géméprost. In this case, the delay was shorter when vaginal administration was made every 6 hours. The evacuation of the uterus was very good, however one aspiration was made three days after abortion. Few side effects were observed with these two drugs: one case of fever, one case of vomiting, both with Sulprostone: two cases of nausea, one case of diarrhoea with Géméprost. We think that the effectiveness is marked and comparable, allowing the use of epidural anesthesia.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
-
English Abstract
MeSH terms
-
Abortifacient Agents / administration & dosage*
-
Abortifacient Agents, Nonsteroidal / administration & dosage*
-
Abortifacient Agents, Nonsteroidal / adverse effects
-
Abortifacient Agents, Nonsteroidal / therapeutic use
-
Administration, Intravaginal
-
Adult
-
Alprostadil / administration & dosage
-
Alprostadil / adverse effects
-
Alprostadil / analogs & derivatives*
-
Alprostadil / therapeutic use
-
Clinical Trials as Topic
-
Dinoprostone / administration & dosage
-
Dinoprostone / adverse effects
-
Dinoprostone / analogs & derivatives*
-
Dinoprostone / therapeutic use
-
Female
-
Fever / chemically induced
-
Gastrointestinal Diseases / chemically induced
-
Humans
-
Infusions, Intravenous
-
Pregnancy
-
Prospective Studies
Substances
-
Abortifacient Agents
-
Abortifacient Agents, Nonsteroidal
-
gemeprost
-
sulprostone
-
Alprostadil
-
Dinoprostone